DK0996435T3 - Aminosyrederivater anvendelige til behandling af slagtilfælde - Google Patents

Aminosyrederivater anvendelige til behandling af slagtilfælde

Info

Publication number
DK0996435T3
DK0996435T3 DK98934465T DK98934465T DK0996435T3 DK 0996435 T3 DK0996435 T3 DK 0996435T3 DK 98934465 T DK98934465 T DK 98934465T DK 98934465 T DK98934465 T DK 98934465T DK 0996435 T3 DK0996435 T3 DK 0996435T3
Authority
DK
Denmark
Prior art keywords
stroke
treatment
amino acid
acid derivatives
derivatives useful
Prior art date
Application number
DK98934465T
Other languages
English (en)
Inventor
Robert H Harris
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of DK0996435T3 publication Critical patent/DK0996435T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98934465T 1997-07-15 1998-07-15 Aminosyrederivater anvendelige til behandling af slagtilfælde DK0996435T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5268497P 1997-07-15 1997-07-15
PCT/US1998/014449 WO1999003460A1 (en) 1997-07-15 1998-07-15 Amino acid derivatives useful to treat stroke

Publications (1)

Publication Number Publication Date
DK0996435T3 true DK0996435T3 (da) 2003-01-27

Family

ID=21979231

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98934465T DK0996435T3 (da) 1997-07-15 1998-07-15 Aminosyrederivater anvendelige til behandling af slagtilfælde

Country Status (10)

Country Link
US (1) US6133261A (da)
EP (1) EP0996435B1 (da)
JP (1) JP4213339B2 (da)
AT (1) ATE225171T1 (da)
AU (1) AU744899B2 (da)
CA (1) CA2296560C (da)
DE (1) DE69808475T2 (da)
DK (1) DK0996435T3 (da)
ES (1) ES2184300T3 (da)
WO (1) WO1999003460A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2419285C (en) 2000-08-25 2011-08-02 Research Corporation Technologies, Inc. New uses for amino acid anticonvulsants
US7794987B2 (en) * 2003-12-02 2010-09-14 Ucb Pharma Gmbh Method for treating central neuropathic pain
KR20070007931A (ko) * 2004-04-16 2007-01-16 쉬바르츠파르마에이지 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도
US7879795B2 (en) 2004-05-21 2011-02-01 Mpex Pharmaceuticals, Inc. Enhancement of tigecycline potency using efflux pump inhibitors
EP1758920A1 (en) * 2004-05-21 2007-03-07 Mpex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors and methods of treating bacterial infections
US20060252749A1 (en) * 2005-01-28 2006-11-09 Srz Properties, Inc. Lacosamide for add-on therapy of psychosis
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
EA019757B1 (ru) 2006-06-15 2014-06-30 ЮСиБи ФАРМА ГМБХ Фармацевтическая композиция с синергетическим противосудорожным эффектом
US8178490B2 (en) * 2007-05-11 2012-05-15 Rempex Pharmaceuticals, Inc. Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
EP2646001A2 (en) 2010-12-02 2013-10-09 UCB Pharma GmbH Formulation of lacosamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654301A (en) * 1985-02-15 1997-08-05 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5331007A (en) * 1987-02-06 1994-07-19 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties

Also Published As

Publication number Publication date
AU8397898A (en) 1999-02-10
AU744899B2 (en) 2002-03-07
ATE225171T1 (de) 2002-10-15
US6133261A (en) 2000-10-17
JP4213339B2 (ja) 2009-01-21
EP0996435B1 (en) 2002-10-02
DE69808475T2 (de) 2003-01-30
ES2184300T3 (es) 2003-04-01
WO1999003460A1 (en) 1999-01-28
EP0996435A1 (en) 2000-05-03
DE69808475D1 (de) 2002-11-07
CA2296560A1 (en) 1999-01-28
JP2002527350A (ja) 2002-08-27
CA2296560C (en) 2006-12-19

Similar Documents

Publication Publication Date Title
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DK1014966T3 (da) Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
FI965203A7 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
ATE380029T1 (de) Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke
BR9804437A (pt) Compostos para a osteoporose
DE69837809D1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
BR9811099A (pt) Inibidores de urocinase
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
ATE253063T1 (de) 5-ht1f-agonisten
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
BR9812837A (pt) Processo para fazer um composto, e, composto
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
DK0807633T3 (da) Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
NO20002408D0 (no) 5-HT1F antagonister